SEC Form 4 · accession 0001104659-15-053878
SYNERGY PHARMACEUTICALS, INC. · SGYP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick Griffin
Officer — Exec VP& Chief Medical Officer
Period of report
Jul 24, 2015
Accepted (ET)
Jul 28, 2015 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001347613
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $7.91 | Jul 24, 2015 | A | 125,000 | A | — | Jul 24, 2025 | Common Stock | 125,000 | 750,000 | D |
Explanation of responses
- F141,667 of the stock options vest on 7/24/2016 and 2017 and 41,666 vest on 7/24/2018.